- Home
- ILPT vs RCEL Comparison
ILPT vs RCEL Comparison
Compare ILPT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- RCEL
- Stock Information
- Founded
- ILPT 2017
- RCEL N/A
- Country
- ILPT United States
- RCEL United States
- Employees
- ILPT N/A
- RCEL N/A
- Industry
- ILPT Real Estate Investment Trusts
- RCEL Medical/Dental Instruments
- Sector
- ILPT Real Estate
- RCEL Health Care
- Exchange
- ILPT Nasdaq
- RCEL Nasdaq
- Market Cap
- ILPT 174.6M
- RCEL 170.8M
- IPO Year
- ILPT 2018
- RCEL N/A
- Fundamental
- Price
- ILPT $3.29
- RCEL $5.62
- Analyst Decision
- ILPT Buy
- RCEL Strong Buy
- Analyst Count
- ILPT 2
- RCEL 4
- Target Price
- ILPT $10.00
- RCEL $17.25
- AVG Volume (30 Days)
- ILPT 371.9K
- RCEL 347.9K
- Earning Date
- ILPT 04-29-2025
- RCEL 05-08-2025
- Dividend Yield
- ILPT 1.22%
- RCEL N/A
- EPS Growth
- ILPT N/A
- RCEL N/A
- EPS
- ILPT N/A
- RCEL N/A
- Revenue
- ILPT $441,992,000.00
- RCEL $71,661,000.00
- Revenue This Year
- ILPT $3.09
- RCEL $59.50
- Revenue Next Year
- ILPT $1.79
- RCEL $28.89
- P/E Ratio
- ILPT N/A
- RCEL N/A
- Revenue Growth
- ILPT 0.61
- RCEL 41.35
- 52 Week Low
- ILPT $2.45
- RCEL $5.46
- 52 Week High
- ILPT $5.45
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- ILPT 55.89
- RCEL 25.54
- Support Level
- ILPT $3.01
- RCEL $6.06
- Resistance Level
- ILPT $3.41
- RCEL $6.38
- Average True Range (ATR)
- ILPT 0.15
- RCEL 0.47
- MACD
- ILPT 0.01
- RCEL -0.11
- Stochastic Oscillator
- ILPT 44.44
- RCEL 8.12
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.